Journal article icon

Journal article

Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections

Abstract:
Background
Patients with Gram-negative bloodstream infections are at risk of serious adverse outcomes without active treatment, but identifying who has antimicrobial resistance (AMR) to target empirical treatment is challenging.
Methods
We used XGBoost machine learning models to predict antimicrobial resistance to seven antibiotics in patients with Enterobacterales bloodstream infection. Models were trained using hospital and community data from Oxfordshire, UK, for patients with positive blood cultures between 01-January-2017 and 31-December-2021. Model performance was evaluated by comparing predictions to final microbiology results in test datasets from 01-January-2022 to 31-December-2023 and to clinicians’ prescribing.
Findings
4709 infection episodes were used for model training and evaluation; antibiotic resistance rates ranged from 7–67%. In held-out test data, resistance prediction performance was similar for the seven antibiotics (AUCs 0.680 [95%CI 0.641–0.720] to 0.737 [0.674–0.797]). Performance improved for most antibiotics when species identifications (available ∼24 h later) were included as model inputs (AUCs 0.723 [0.652–0.791] to 0.827 [0.797–0.857]). In patients treated with a beta-lactam, clinician prescribing led to 70% receiving an active beta-lactam: 44% were over-treated (broader spectrum treatment than needed), 26% optimally-treated (narrowest spectrum active agent), and 30% under-treated (inactive beta-lactam). Model predictions without species data could have led to 79% of patients receiving an active beta-lactam: 45% over-treated, 34% optimally-treated, and 21% under-treated.
Conclusions
Predicting AMR in bloodstream infections is challenging for both clinicians and models. Despite modest performance, machine learning models could still increase the proportion of patients receiving active empirical treatment by up to 9% over current clinical practice in an environment prioritising antimicrobial stewardship.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.jinf.2024.106388

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Big Data Institute - NDPH
Oxford college:
Exeter College
Role:
Author
ORCID:
0000-0003-1283-2712
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Big Data Institute
Oxford college:
Green Templeton College
Role:
Author
ORCID:
0000-0001-9621-529X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
ORCID:
0000-0002-0412-8509
More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Engineering Science
Sub department:
Institute of Biomedical Engineering
Oxford college:
Kellogg College
Role:
Author
ORCID:
0000-0002-1552-5630


Publisher:
Elsevier
Journal:
Journal of Infection More from this journal
Volume:
90
Issue:
2
Article number:
106388
Publication date:
2024-12-29
Acceptance date:
2024-12-20
DOI:
EISSN:
1532-2742
ISSN:
0163-4453


Language:
English
Keywords:
Pubs id:
2074016
Local pid:
pubs:2074016
Deposit date:
2025-01-05
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP